MEDROXYPROGESTERONE ACETATE (MEDROXYPROGESTERONE ACETATE) — FDA Approval ANDA210335 (CIPLA)
MEDROXYPROGESTERONE ACETATE (MEDROXYPROGESTERONE ACETATE) — FDA Approval ANDA210335 (CIPLA) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: MEDROXYPROGESTERONE ACETATE; Active ingredients: MEDROXYPROGESTERONE ACETATE; Application number: ANDA210335.
| Brand name | MEDROXYPROGESTERONE ACETATE |
|---|---|
| Active ingredients | MEDROXYPROGESTERONE ACETATE |
| Application number | ANDA210335 |
| Sponsor | CIPLA |
| Dosage form | INJECTABLE |
| Route | INJECTION |
| Marketing status | Discontinued |
| Products in application | 1 |
| First approval date | 20190125 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →